Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2307393
Reference Type
Journal Article
Subtype
Abstract
Title
Heavy metal-mediated lipid signaling in vascular endothelial cells: methylmercury-induced phospholipase D regulation by phospholipase A(2) and eicosanoids
Author(s)
Sherwai, S; Pabon, S; Kuppusamy, M; Sayyid, M; Kotha, S; Maddipati, K; Parinandi, N
Year
2008
Is Peer Reviewed?
Yes
Journal
Free Radical Biology and Medicine
ISSN:
0891-5849
EISSN:
1873-4596
Volume
45
Issue
Suppl.
Page Numbers
S150-S150
Language
English
Web of Science Id
WOS:000260867900425
URL
http://www.sciencedirect.com/science/article/pii/S0891584908006321
Exit
Relationship(s)
is part of a larger document
3452652
SFRBM's 15th Annual Meeting: Program and Abstracts
Abstract
Mercury, especially MeHg, is implicated in the etiology of cardiovascular diseases. Hence, we investigated the mechanism of MeHg-induced phospholipase D (PLD) activation through the upstream regulation of PLA2, cyclooxygenase (COX) and lipoxygenase (LOX) as an underlying lipid signaling mechanism of MeHg-induced endothelial dysfunctions in the bovine pulmonary artery endothelial cells (BPAECs). Our results showed that MeHg significantly activated both PLA2 (as determined by the release of [3H]arachidonic acid, AA) and PLD (by the formation of [32P]phosphatidylbutanol) in BPAECs in a dose- (0 to 10 μM) and time-dependent (0 to 60 min) manner. the cPLA2-specific inhibitor, AACOCF3, significantly attenuated the MeHg-induced [3H]AA release, suggesting that MeHg activated cPLA2 in ECs. Furthermore, the MeHg-induced PLD activation was also inhibited by AACOCF3, indicating that the activation of cPLA2 was upstream of activation of PLD in BPAECs. the COX-specific inhibitors (aspirin, ibuprofen, indomethacin, and nimesulide) and the LOX-specific inhibitors (caffeic acid, ETI, ETYA and baicalein) significantly attenuated the MeHg-induced PLD activation, suggesting that COXs and LOXs were involved in the MeHg induced activation of PLD in ECs. Liquid chromatography-mass spectrometry analysis showed that MeHg also significantly induced the formation of COX- and LOX-catalyzed eicosanoids in ECs, confirming the activation of COXs and LOXs by MeHg. For the first time, we showed that MeHg activated PLD in ECs through the activation of cPLA2 and eicosanoids formed by COXs and LOXs.
Conference Name
Society for Free Radical Biology and Medicine 15th Annual Meeting
Conference Location
Indianapolis, IN
Conference Dates
November 19-23, 2008
Tags
IRIS
•
Methylmercury
Literature Search: Jan 1998 - March 2017
Web of Science
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity